Mark Mallon - Insider Trading & Ownership

Entity
Individual
Location
C/O Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston, MA
Summary
The estimated net worth of Mark Mallon is at least $6.77M dollars as of March 3, 2022. Mark Mallon is the Chief Executive Officer, Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $6.77M.
All Insider Reports
All Insider Reports

Ownership of Mark Mallon

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NEO NEOGENOMICS INC Chief Executive Officer, Director $6.77M Mar 1, 2022

Insider Transactions Reported by Mark Mallon:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.